Viewing Study NCT00410566

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:04 PM
Ignite Modification Date: 2026-02-02 @ 5:21 PM
Study NCT ID: NCT00410566
Status: TERMINATED
Last Update Posted: 2015-03-19
First Post: 2006-12-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease)
Sponsor: Genzyme, a Sanofi Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acid Sphingomyelinase Deficiency View
None Niemann-Pick Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acid sphingomyelinase deficiency View
None Niemann-Pick disease View
None Lysosomal storage disorder View
None Enzyme replacement therapy View
None Treatment View